@misc{indiciaea84e1f756ac4,
  title = {DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinoma},
  author = {Jeanneret, F. and Schoch, S. and Ballester, P. and Symeonides, S. N. and Laird, A. and Axelson, H. and Pflieger, D. and Battail, C.},
  year = {2024},
  doi = {10.1101/2024.11.05.622095},
  url = {https://www.biorxiv.org/content/10.1101/2024.11.05.622095v1},
  note = {Source identifier: 10.1101/2024.11.05.622095}
}